Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

63
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
63
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

99
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
99
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

36
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
36
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Emotion Classification in Japanese Cancer Survivor Interview Narratives Using Sentiment Polarity and Plutchik Emotion Frameworks: Model Development and Evaluation Study.

JMIR formative research·2026
Same author

DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Automating the roter interaction analysis system for medication counseling: A transformer-based deep learning approach with generative AI-augmented data.

Research in social & administrative pharmacy : RSAP·2026
Same author

Author Correction: Acarbose redirects gut microbiome utilization of dietary carbohydrates to suppress anaphylaxis in mice.

Nature microbiology·2026
Same author

Protective Effect of Vitamin E Against Vancomycin-Induced Nephrotoxicity: A Large-Scale Electronic Medical Record Study From Japan.

Basic & clinical pharmacology & toxicology·2026
Same author

Acarbose redirects gut microbiome utilization of dietary carbohydrates to suppress anaphylaxis in mice.

Nature microbiology·2026

相关实验视频

Updated: Jun 11, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

数据驱动的临床药学研究:利用机器学习和医疗大数据.

Shungo Imai1

  • 1Division of Drug Informatics, Keio University Faculty of Pharmacy.

Biological & pharmaceutical bulletin
|October 2, 2024
PubMed
概括

机器学习和医疗大数据克服了临床药房研究的局限性. 这种方法增强了风险预测范胺诱导的急性损伤,并优化了药物剂量.

科学领域:

  • 临床药房 临床药房
  • 医疗信息学 医疗信息学
  • 机器学习在医学中的应用

背景情况:

  • 传统的临床药学研究面临传统统计和单中心研究的局限性.
  • 需要先进的方法来分析复杂的医疗数据,克服机构偏见.

研究的目的:

  • 探索使用机器学习和医疗大数据的数据驱动方法,以加强临床药房研究.
  • 开发和验证用于急性损伤风险预测和万科米辛剂量的机器学习模型.

主要方法:

  • 利用决策树分析,一种机器学习技术,用于风险预测和剂量估计.
  • 使用日本医疗大数据,包括索赔数据库,以克服单中心研究的局限性.
  • 开发了用于预测急性损伤和估计最佳万科米辛剂量的模型.

主要成果:

  • 成功开发了一种风险预测模型,用于万科米辛诱导的急性损伤.
  • 与传统算法相比,用于估计最佳万科米辛初始剂量的模型显示出更高的准确性.
  • 机器学习和大数据的整合产生了高质量的,可概括的临床证据.

结论:

  • 机器学习与医疗大数据相结合,提供了一种强大的方法来解决临床药房研究的局限性.
关键词:
药物不良反应 药物不良反应临床药房研究临床药房研究决策树的分析机器学习是机器学习.医疗大数据的大数据风险预测模型的风险预测模型

更多相关视频

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications
09:20

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

8.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

相关实验视频

Last Updated: Jun 11, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications
09:20

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

8.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
  • 这种数据驱动的方法允许产生具有临床价值的发现和高质量的证据.
  • 该研究强调了通过创新的数据分析技术来推进制药研究和患者护理的潜力.